The prognosis of patients with myelodysplastic syndromes (MDS), who are red blood cell transfusion-dependent (TD) and receive supportive care is inferior compared to that of patients not requiring transfusions. higher comorbidity index (p=0.01), and OS was inferior among patients with ferritin levels >1000g/l before PBSCT (p=0.03). In multivariate analysis only marrow myeloblast count (p=0.01) and… Continue reading The prognosis of patients with myelodysplastic syndromes (MDS), who are red